Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Varonis To Contact Him Directly To Discuss Their Options NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Varonis Systems, Inc. ("Varonis" or the "Company") (NASDAQ: VRNS) and reminds investors of the March 9, 2026 deadline to seek the role of lead plaintiff in a federal securities class action t ...

Core Insights - Apple has launched a new series of MacBook laptops starting at a price of $1,099, aiming to attract customers in a declining PC market [1] Company Summary - The new MacBook series is part of Apple's strategy to introduce new hardware offerings [1] - The launch comes at a time when the PC market is facing challenges, particularly due to issues related to memory chip supply [1] Industry Summary - The PC market is currently experiencing a contraction, which has prompted companies like Apple to innovate and release new products [1] - The introduction of new hardware by Apple may influence competitive dynamics within the shrinking PC market [1]

Core Viewpoint - A securities class action lawsuit has been filed against former top executives of Zynex, Inc. for alleged systematic overbilling and a "zombie" revenue scheme, following the company's stock delisting and Chapter 11 filing [1] Group 1: Legal Issues - The lawsuit is initiated by Hagens Berman, a national shareholder rights law firm, indicating significant legal challenges for Zynex, Inc. [1] - The case is titled Beidel v. Zynex, highlighting the formal nature of the allegations against the company's executives [1] Group 2: Stock Performance - Zynex's common stock was traded on the NASDAQ under the symbol "ZYXI" before its suspension on December 24, 2025, and has since been trading over the counter as "ZYXIQ" [1]

Core Insights - AutoZone reported quarterly earnings of $27.63 per share, exceeding the Zacks Consensus Estimate of $27.1 per share, but down from $28.29 per share a year ago, resulting in an earnings surprise of +1.94% [1] - The company generated revenues of $4.27 billion for the quarter, missing the Zacks Consensus Estimate by 0.82%, compared to $3.95 billion in the same quarter last year [2] - AutoZone's stock has increased by approximately 14.5% year-to-date, significantly outperforming the S&P 500's gain of 0.5% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $36.30, with expected revenues of $4.83 billion, and for the current fiscal year, the EPS estimate is $148.80 on revenues of $20.48 billion [7] - The trend of earnings estimate revisions for AutoZone was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Automotive - Retail and Wholesale - Parts industry, to which AutoZone belongs, is currently ranked in the bottom 20% of over 250 Zacks industries, suggesting potential challenges ahead [8]

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive's content includes insights across various sectors such as biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] Group 2 - Proactive has a strong focus on technology adoption, utilizing tools to enhance workflows while maintaining human oversight in content creation [4][5] - The company employs automation and software tools, including generative AI, but ensures all content is edited and authored by humans [5]

Core Viewpoint - Academy Sports + Outdoors is set to release its fourth quarter and fiscal 2025 financial results on March 17, 2026, and will host a conference call to discuss these results [1] Group 1: Financial Results Announcement - The financial results will be released before the market opens on March 17, 2026 [1] - A live conference call is scheduled for 10:00 a.m. Eastern Time on the same day to discuss the results [1] - Participants can access the call by dialing specific numbers for U.S. and international callers, with a passcode provided [1] Group 2: Company Background - Academy Sports + Outdoors is a leading full-line sporting goods and outdoor recreation retailer in the United States [1] - The company was founded in 1938 in Texas and has expanded to over 300 stores across 21 states [1] - The company's mission is to provide "Fun for All" through a localized merchandising strategy that appeals to a diverse consumer base [1] Group 3: Product Offering - Academy's product assortment includes key categories such as outdoor, apparel, sports & recreation, and footwear [1] - The company offers both leading national brands and a portfolio of private label brands [1]

Core Viewpoint - VIS-101 is a dual VEGF-A/ANG-2 inhibitor designed to offer more effective and durable treatment for patients with wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO) [1][2][11] Company Overview - NovaBridge Biosciences is a global biotechnology platform company focused on accelerating access to innovative medicines [7] - The company combines business development expertise with clinical development to advance breakthrough assets [7] - NovaBridge is the majority shareholder of Visara, which holds global rights to VIS-101 outside of Greater China and certain Asian territories [3][6] Product Development - VIS-101 is currently undergoing a randomized, dose-ranging Phase 2a study for wet AMD [2][11] - The product is designed to provide potent and durable treatment benefits for wet AMD, DME, and RVO [2][11] - The company will host a virtual business update call to review Phase 2a clinical data for VIS-101 on March 9, 2026 [1] Pipeline and Collaborations - NovaBridge's pipeline includes givastomig, a bispecific antibody targeting Claudin 18.2 for gastric cancer, and ragistomig, a bispecific antibody for solid tumors [8][10] - The company also owns worldwide rights to uliledlimab, an anti-CD73 antibody targeting immunosuppression in cancer [10]

Core Insights - Xometry, Inc. has launched its new Enterprise Machining Lead Time Prediction Model and enhanced dynamic pricing logic, which aim to improve prediction accuracy, operational efficiency, and rapid lead-time options for custom manufacturing [1][2] Group 1: New Model Features - The Enterprise Machining Lead Time Prediction Model leverages deep learning from real-world production and delivery data, enhancing the Instant Quoting Engine's capabilities [3][4] - The model provides superior prediction accuracy, achieving significant improvements in RMSLE compared to previous versions, and optimizes for 1-day lead times across a growing catalog of materials and geometries [8] - The updated model incorporates a training dataset four times larger than previous versions and factors in critical overhead requirements, including specialized certifications and advanced finishing options [8] Group 2: Operational Enhancements - Xometry's dynamic pricing logic analyzes unique geometric features and customer-specific historical data to create a price-response function for each quote, moving away from static pricing rules [5][4] - The new models are expected to improve the buyer and partner experience while increasing revenue per user, with broader deployment to U.S. customers planned for Q1 2026 [6] - The integration of pricing and sourcing models within live marketplace transactions creates a closed-loop learning system that enhances future predictions and operational throughput [9] Group 3: Strategic Implications - The advancements represent a fundamental shift in manufacturing speed and reliability, allowing Xometry to address complex sourcing challenges that traditional software cannot [7] - By embedding design-to-fulfillment intelligence into engineers' workflows, Xometry aims to reduce information asymmetry in manufacturing procurement, transforming the process into a scalable competitive advantage [10]

Core Viewpoint - Canaan Inc.'s CEO and CFO have purchased shares in the company, reflecting their confidence in its long-term strategy and growth potential, as they believe the current market valuation does not fully represent the company's strengths [1]. Group 1: Share Purchases - The CEO, Nangeng Zhang, and CFO, Jin Cheng, acquired a total of 1,456,547 American Depositary Shares (ADSs) at an average price of US$0.51 per ADS [1]. - These purchases were made in compliance with the company's internal trading policies and applicable securities regulations [1]. Group 2: Company Background - Canaan Inc. was established in 2013 and focuses on ASIC high-performance computing chip design, chip research and development, computing equipment production, and software services [1]. - The company has a significant presence in the global bitcoin mining market, holding the second largest market share with its Avalon brand of mining machines [1]. - Canaan completed its initial public offering on the Nasdaq Global Market in 2019 [1].

For the first quarter, it guided to adjusted EPS of about 16 cents, above the 13 cents analyst estimate, and adjusted EBITDA of about $515 million. Photo via Shutterstock Norwegian Cruise shares dipped 3.7% to $21.36 in pre-market trading. Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) on Monday reported fourth-quarter results that topped earnings expectations but missed on revenue and included a cut to its full-year 2026 adjusted profit outlook. Fourth-quarter total revenue was $2.244 billion, up 6% from ...